Hyperaldosteronism

Last updated: January 26, 2026

Hyperaldosteronism

Watch later

Watch later

Somatostatin
Synthesis of adrenocortical hormones
Cortisol
Testosterone
Estrogen and progesterone
Phosphate, calcium and magnesium homeostasis
Parathyroid hormone
Vitamin D
Calcitonin
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Thyroglossal duct cyst
Hyperthyroidism
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetic retinopathy
Diabetic nephropathy
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Pheochromocytoma
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Bones of the cranium
Anatomy of the cranial base
Anatomy of the orbit
Anatomy of the eye
Bones of the neck
Superficial structures of the neck: Cervical plexus
Superficial structures of the neck: Anterior triangle
Deep structures of the neck: Prevertebral muscles
Anatomy of the thyroid and parathyroid glands
Anatomy of the larynx and trachea
Anatomy of the pharynx and esophagus
Introduction to the cranial nerves
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Nasal cavity and larynx histology
Anatomy and physiology of the eye
Photoreception
Optic pathways and visual fields
Anatomy and physiology of the ear
Auditory transduction and pathways
Vestibular transduction
Vestibulo-ocular reflex and nystagmus
Olfactory transduction and pathways
Taste and the tongue
Glaucoma
Retinoblastoma
Laryngomalacia
Laryngitis
Bacterial epiglottitis
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Vertigo: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Antihistamines for allergies
Acid reducing medications
Blood histology
Sepsis
Anaphylaxis
Food allergy
Blood products and transfusion: Clinical
Bites and stings: Clinical
Hematopoietic medications
Thrombolytics
Hemophilia
The nurse and doctor and the avoidable lawsuit (Coverys)
Traumatic brain injury: Pathology review
Concussion and traumatic brain injury
Traumatic brain injury: Clinical
Brain herniation
Drug administration and dosing regimens
Sympathomimetics: Direct agonists
Muscarinic antagonists
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Laxatives and cathartics
Antidiarrheals
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Nonbenzodiazepine anticonvulsants
Migraine medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Opioid antagonists
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
PDE5 inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Aromatase inhibitors
Uterine stimulants and relaxants
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines

Transcript

Watch video only

With hyperaldosteronism, "hyper" means too much, and "aldosteronism" refers to the hormone aldosterone, which is made by the adrenal glands. So, hyperaldosteronism is a condition where the adrenal glands produce too much aldosterone.

Now, each of the two adrenal glands sits on top of a kidney and has two main parts.

The inner part, the medulla, produces the hormones epinephrine and norepinephrine.

On the flip side, the outer part, the cortex, has three layers. The innermost layer, the zona reticularis, produces androgens, such as dehydroepiandrosterone, which is a precursor of testosterone. The middle layer, the zona fasciculata, produces glucocorticoids, like cortisol. With glucocorticoids, “gluco-” refers to glucose, because they help increase blood glucose levels. The outermost layer, the zona glomerulosa, produces mineralocorticoids, such as aldosterone. With mineralocorticoids, “mineralo-” refers to minerals, because these hormones help regulate sodium and potassium levels. Now, the zona glomerulosa is controlled by the renin-angiotensin-aldosterone system.

When blood pressure or sodium levels drop, the juxtaglomerular cells in the kidneys release renin into the bloodstream. In the bloodstream, renin cleaves angiotensinogen into angiotensin I, which is later converted by angiotensin-converting enzyme or ACE, into angiotensin II.

Angiotensin II raises blood pressure through two mechanisms.

First, it triggers vasoconstriction of small arterioles, subsequently increasing peripheral vascular resistance. Second, angiotensin II stimulates the zona glomerulosa to release aldosterone.

Once in the bloodstream, aldosterone travels to the kidneys, more specifically, to the distal tubules and collecting ducts of the nephron.

Here, aldosterone squeezes into principal cells and stimulates mineralocorticoid receptors. When aldosterone activates mineralocorticoid receptors, the sodium-potassium pumps kick into high gear.
They begin to pump more sodium ions from the cell into the bloodstream.

This intracellular drop in sodium pulls more sodium from the tubule into the cell, following its concentration gradient. As sodium moves, water follows, so more water leaves the tubule and enters the blood vessels, eventually increasing blood volume and raising blood pressure.

At the same time, pumps pull potassium from the blood into the cells.

From here, potassium flows down its concentration gradient into the tubule to get excreted in the urine. That’s why another key trigger for the zona glomerulosa to release aldosterone is a high potassium level in the blood. Aldosterone helps the body remove extra potassium while holding on to sodium and water.

Now, based on the underlying pathology, hyperaldosteronism can be further subdivided into primary- and secondary types.

Primary hyperaldosteronism means that the adrenal glands are responsible for the excess production of aldosterone. The most common cause of primary hyperaldosteronism is bilateral idiopathic hyperaldosteronism. “Bilateral” means it affects both adrenal glands, and “idiopathic” means we’re not sure what’s causing it. But if we slice through the adrenal glands, we can recognize this condition by focal or widespread hyperplasia of cells that resemble those in the zona glomerulosa, which produce aldosterone.

Next, there are adrenocortical neoplasms.

Sources

  1. "Robbins & Kumar Basic Pathology. Available from: ClinicalKey Student, (11th Edition). Page 668-669 " Elsevier Limited (UK) (2022)
  2. "Robbins & Cotran Pathologic Basis of Disease. Available from: ClinicalKey Student, (10th Edition). Page 1118-1119 " Elsevier Health Sciences (US) (2020)
  3. "USMLE Step 1 Secrets in Color. Available from: ClinicalKey Student, (5th Edition). Page 174 " Elsevier Limited (UK) (2022)
  4. "Conn's Current Therapy 2024. Available from: ClinicalKey Student, Page 343-345 " Elsevier Limited (UK) (2023)
  5. "Textbook of Medical Physiology. Available from: ClinicalKey Student, (14th Edition). Page 955-962 " Elsevier Health Sciences (US) (2020)